Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
CDC25A | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 9.88E3 | Evidence | |||||
CDC25A | PLK1 | PLK1, PLK: Serine/threonine-protein kinase PLK1 | 6.48E3 | Evidence | |||||
CDC25A | CCNB2 | CCNB2: G2/mitotic-specific cyclin-B2 | 3.84E3 | Evidence | |||||
CDC25A | CDK2 | CDK2: Cell division protein kinase 2 | 504.0 | Evidence | |||||
CDC25A | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 33.90 | Evidence | |||||
CDC25A | CDC2L1 | CDC2L1, PITSLREA, PK58: PITSLRE serine/threonine-protein kinase CDC2L1 | 22.90 | Evidence | |||||
CDC25A | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 22.90 | Evidence | |||||
CDC25A | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence | |||||
CDC25A | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence | |||||
CDC25A | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 20.50 | Evidence | |||||
CDC25A | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
CDC25A | STK38L | STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like | 20.50 | Evidence | |||||
CDC25A | STK38 | STK38, NDR1: Serine/threonine-protein kinase 38 | 20.50 | Evidence | |||||
CDC25A | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 20.50 | Evidence | |||||
CDC25A | CDC7 | CDC7, CDC7L1: Cell division cycle 7-related protein kinase | 20.50 | Evidence | |||||
CDC25A | YWHAG | YWHAG: 14-3-3 protein gamma | 19.70 | Evidence | |||||
CDC25A | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 19.70 | Evidence | |||||
CDC25A | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 17.60 | Evidence | |||||
CDC25A | CSK | CSK: Tyrosine-protein kinase CSK | 17.60 | Evidence | |||||
CDC25A | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 17.60 | Evidence | |||||
CDC25A | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 17.60 | Evidence | |||||
CDC25A | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 17.60 | Evidence | |||||
CDC25A | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 17.60 | Evidence | |||||
CDC25A | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 17.60 | Evidence | |||||
CDC25A | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 17.60 | Evidence | |||||
CDC25A | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 15.00 | Evidence | |||||
CDC25A | MAP3K5 | MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 | 15.00 | Evidence | |||||
CDC25A | INSR | INSR: Insulin receptor precursor | 13.50 | Evidence | |||||
CDC25A | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 13.50 | Evidence | |||||
CDC25A | STK25 | STK25, SOK1, YSK1: Serine/threonine-protein kinase 25 | 13.40 | Evidence | |||||
CDC25A | RBL2 | RBL2, RB2: Retinoblastoma-like protein 2 | 13.40 | Evidence | |||||
CDC25A | WEE1 | WEE1: Wee1-like protein kinase | 13.40 | Evidence | |||||
CDC25A | CDK7 | CDK7, MO15: Cell division protein kinase 7 | 13.40 | Evidence | |||||
CDC25A | CCNE1 | CCNE1, CCNE: G1/S-specific cyclin-E1 | 13.40 | Evidence | |||||
CDC25A | PBK | PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase | 13.40 | Evidence | |||||
CDC25A | PKMYT1 | PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito | 13.40 | Evidence | |||||
CDC25A | PRPF4B | PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol | 13.40 | Evidence | |||||
CDC25A | CCNH | CCNH: Cyclin-H | 13.40 | Evidence | |||||
CDC25A | RBL1 | RBL1: Retinoblastoma-like protein 1 | 13.40 | Evidence | |||||
CDC25A | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 11.60 | Evidence | |||||
CDC25A | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 11.60 | Evidence | |||||
CDC25A | TGFBR1 | TGFBR1: TGF-beta receptor type-1 precursor | 11.60 | Evidence | |||||
CDC25A | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 11.60 | Evidence | |||||
CDC25A | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 6.80 | Evidence | |||||
CDC25A | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 6.50 | Evidence | |||||
CDC25A | MCM4 | MCM4, CDC21: DNA replication licensing factor MCM4 | 5.73 | Evidence | |||||
CDC25A | MCM2 | MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 | 5.73 | Evidence | |||||
CDC25A | EIF2S2 | EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 | 5.73 | Evidence | |||||
CDC25A | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 3.88 | Evidence | |||||
CDC25A | IRS2 | IRS2: Insulin receptor substrate 2 | 3.88 | Evidence | |||||
CDC25A | MATK | 3.88 | Evidence | ||||||
CDC25A | MNAR | PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 | 3.88 | Evidence | |||||
CDC25A | MARK2 | N/A | 3.88 | Evidence | |||||
CDC25A | BID | BID: BH3-interacting domain death agonist | 3.88 | Evidence | |||||
CDC25A | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 3.88 | Evidence | |||||
CDC25A | RNPS1 | RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 | 3.88 | Evidence | |||||
CDC25A | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 3.88 | Evidence | |||||
CDC25A | KRT18 | KRT18: Uncharacterized protein KRT18 | 3.88 | Evidence | |||||
CDC25A | LOC642558 | FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 | 3.88 | Evidence | |||||
CDC25A | CCNB1 | Cyclin B1 | 3.65 | Evidence | |||||
CDC25A | CDC6 | CDC6, CDC18L: Cell division control protein 6 homolog | 3.47 | Evidence | |||||
CDC25A | HDAC5 | HDAC5, KIAA0600: Histone deacetylase 5 | 3.47 | Evidence | |||||
CDC25A | TUBB2A | TUBB2A, TUBB2: Tubulin beta-2A chain | 3.47 | Evidence | |||||
CDC25A | MICAL-L1 | MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 | 3.47 | Evidence | |||||
CDC25A | MAD1L1 | MAD1L1, MAD1, TXBP181: Mitotic spindle assembly checkpoint protein MAD1 | 3.47 | Evidence | |||||
CDC25A | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 3.47 | Evidence | |||||
CDC25A | ZFP36 | ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline | 3.47 | Evidence | |||||
CDC25A | PARD3 | N/A | 3.47 | Evidence | |||||
CDC25A | TDG | TDG: G/T mismatch-specific thymine DNA glycosylase | 3.47 | Evidence | |||||
CDC25A | DNAJC7 | DNAJC7, TPR2, TTC2: DnaJ homolog subfamily C member 7 | 3.47 | Evidence | |||||
CDC25A | KIAA0788 | ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase | 3.47 | Evidence | |||||
CDC25A | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 3.47 | Evidence | |||||
CDC25A | TSC2 | TSC2, TSC4: Tuberin | 3.47 | Evidence | |||||
CDC25A | CDC23 | CDC23: Cell division cycle protein 23 homolog | 3.47 | Evidence | |||||
CDC25A | PIK4CB | PIK4CB, RP11-126K1.4-003, hCG_1811976: Phosphatidylinositol 4-kinase, catalytic, | 3.47 | Evidence | |||||
CDC25A | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 3.47 | Evidence | |||||
CDC25A | RIN1 | RIN1: Ras and Rab interactor 1 | 3.47 | Evidence | |||||
CDC25A | TSC1 | TSC1, KIAA0243, TSC: Hamartin | 3.47 | Evidence | |||||
CDC25A | CDC25C | CDC25C: M-phase inducer phosphatase 3 | 3.47 | Evidence | |||||
CDC25A | EIF2S3 | EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 | 3.47 | Evidence | |||||
CDC25A | CDKN1B | CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B | 3.47 | Evidence | |||||
CDC25A | NRAS | NRAS, HRAS1: GTPase NRas precursor | 3.47 | Evidence | |||||
CDC25A | IRS1 | IRS1: Insulin receptor substrate 1 | 3.34 | Evidence | |||||
CDC25A | CREBBP | CREBBP, CBP: CREB-binding protein | 2.99 | Evidence | |||||
CDC25A | MCM3 | MCM3: DNA replication licensing factor MCM3 | 2.99 | Evidence | |||||
CDC25A | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 2.99 | Evidence | |||||
CDC25A | FZR1 | N/A | 2.99 | Evidence | |||||
CDC25A | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 2.99 | Evidence | |||||
CDC25A | SMAD1 | SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 | 2.99 | Evidence | |||||
CDC25A | ATR | ATR, FRP1: Serine/threonine-protein kinase ATR | 2.99 | Evidence | |||||
CDC25A | CCNE2 | CCNE2: G1/S-specific cyclin-E2 | 2.85 | Evidence | |||||
CDC25A | COIL | COIL, CLN80: Coilin | 2.54 | Evidence | |||||
CDC25A | ERF | ERF: ETS domain-containing transcription factor ERF | 2.54 | Evidence | |||||
CDC25A | TP73 | TP73, P73: Tumor protein p73 | 2.54 | Evidence | |||||
CDC25A | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 2.54 | Evidence | |||||
CDC25A | ZFP91 | ZFP91, FKSG11: Zinc finger protein 91 homolog | 2.54 | Evidence | |||||
CDC25A | CDKN1A | CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi | 2.54 | Evidence | |||||
CDC25A | VASP | VASP: Vasodilator-stimulated phosphoprotein | 2.54 | Evidence | |||||
CDC25A | ID3 | ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 | 2.54 | Evidence | |||||
CDC25A | CEBPA | CEBPA: CCAAT/enhancer-binding protein alpha | 2.54 | Evidence | |||||
CDC25A | BAZ1B | BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain | 2.54 | Evidence | |||||
CDC25A | CASP6 | CASP6, MCH2: Caspase-6 precursor | 2.54 | Evidence | |||||
CDC25A | H1FX | H1FX: Histone H1x | 2.54 | Evidence | |||||
CDC25A | TSPYL2 | TSPYL2, CDA1, HRIHFB2216, DENTT, TSPX: Testis-specific Y-encoded-like protein 2 | 2.54 | Evidence | |||||
CDC25A | STRN3 | STRN3, GS2NA, SG2NA: Striatin-3 | 2.54 | Evidence | |||||
CDC25A | PTMA | N/A | 2.54 | Evidence | |||||
CDC25A | SNRPB | N/A | 2.54 | Evidence | |||||
CDC25A | ESPL1 | N/A | 2.54 | Evidence | |||||
CDC25A | CCNF | CCNF: G2/mitotic-specific cyclin-F | 2.43 | Evidence | |||||
CDC25A | CHAF1B | CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B | 2.28 | Evidence | |||||
CDC25A | NPM1 | NPM1, NPM: Nucleophosmin | 2.28 | Evidence | |||||
CDC25A | TCEB3 | TCEB3, MSTP059: Transcription elongation factor B polypeptide 3 | 2.28 | Evidence | |||||
CDC25A | HNRPM | HNRPM, NAGR1: Heterogeneous nuclear ribonucleoprotein M | 2.28 | Evidence | |||||
CDC25A | MYBL2 | MYBL2, BMYB: Myb-related protein B | 2.28 | Evidence | |||||
CDC25A | FKBP5 | FKBP5, AIG6, FKBP51: FK506-binding protein 5 | 2.28 | Evidence | |||||
CDC25A | USP47 | USP47: Ubiquitin carboxyl-terminal hydrolase 47 | 2.28 | Evidence | |||||
CDC25A | SALL1 | SALL1, SAL1: Sal-like protein 1 | 2.28 | Evidence | |||||
CDC25A | HIST1H1B | HIST1H1B, H1F5: Histone H1.5 | 2.28 | Evidence | |||||
CDC25A | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 2.28 | Evidence | |||||
CDC25A | HTATIP | N/A | 2.28 | Evidence | |||||
CDC25A | SEC24C | SEC24C, KIAA0079: Protein transport protein Sec24C | 2.28 | Evidence | |||||
CDC25A | DGKD | DGKD, KIAA0145: Diacylglycerol kinase delta | 2.28 | Evidence | |||||
CDC25A | RASA3 | RASA3: Ras GTPase-activating protein 3 | 2.28 | Evidence | |||||
CDC25A | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 2.28 | Evidence | |||||
CDC25A | BRCA1 | BRCA1, RNF53: Breast cancer type 1 susceptibility protein | 2.28 | Evidence | |||||
CDC25A | HIRA | HIRA, DGCR1, HIR, TUPLE1: Protein HIRA | 2.28 | Evidence | |||||
CDC25A | UBE2A | UBE2A, RAD6A: Ubiquitin-conjugating enzyme E2 A | 2.28 | Evidence | |||||
CDC25A | HIST1H3A | HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, | 2.28 | Evidence | |||||
CDC25A | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 2.28 | Evidence | |||||
CDC25A | NFYA | NFYA: Nuclear transcription factor Y subunit alpha | 2.28 | Evidence | |||||
CDC25A | ORC1L | ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 | 2.28 | Evidence | |||||
CDC25A | PCNA | PCNA: Proliferating cell nuclear antigen | 2.28 | Evidence | |||||
CDC25A | PIK3R4 | PIK3R4: Phosphoinositide 3-kinase regulatory subunit 4 | 2.17 | Evidence | |||||
CDC25A | PRKCH | PRKCH, PKCL, PRKCL: Protein kinase C eta type | 2.17 | Evidence | |||||
CDC25A | PLK4 | PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 | 2.17 | Evidence | |||||
CDC25A | CCNA2 | CCNA2, CCN1, CCNA: Cyclin-A2 | 2.17 | Evidence | |||||
CDC25A | PTPNS1 | N/A | 1.98 | Evidence | |||||
CDC25A | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 1.53 | Evidence | |||||
CDC25A | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 1.30 | Evidence | |||||
CDC25A | LYPD3 | LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor | 1.30 | Evidence | |||||
CDC25A | SLC4A3 | SLC4A3, AE3: Anion exchange protein 3 | 1.30 | Evidence | |||||
CDC25A | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 1.16 | Evidence | |||||
CDC25A | TPR | TPR: Nucleoprotein TPR | 1.16 | Evidence | |||||
CDC25A | HIST2H2BE | HIST2H2BE, H2BFQ: Histone H2B type 2-E | 1.15 | Evidence | |||||
CDC25A | NCF2 | NCF2: Neutrophil cytosol factor 2 | 1.13 | Evidence | |||||
CDC25A | CDK3 | CDK3: Cell division protein kinase 3 | 1.10 | Evidence | |||||
CDC25A | ERN2 | ERN2, IRE2: Serine/threonine-protein kinase/endoribonuclease IRE2 precursor | 0.968 | Evidence | |||||
CDC25A | NEDD4L | N/A | 0.932 | Evidence | |||||
CDC25A | BAD | BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death | 0.675 | Evidence | |||||
CDC25A | ARPC4 | ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 | 0.675 | Evidence | |||||
CDC25A | TPH1 | N/A | 0.675 | Evidence | |||||
CDC25A | PPIA | PPIA, CYPA: Peptidyl-prolyl cis-trans isomerase A | 0.618 | Evidence | |||||
CDC25A | ZA20D1 | OTUD7B, ZA20D1: OTU domain-containing protein 7B | 0.605 | Evidence | |||||
CDC25A | CTSZ | CTSZ: Cathepsin Z precursor | 0.475 | Evidence | |||||
CDC25A | PGAM1 | PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 | 0.475 | Evidence | |||||
CDC25A | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 0.41 | Evidence | |||||
CDC25A | FEN1 | FEN1, RAD2: Flap endonuclease 1 | 0.398 | Evidence | |||||
CDC25A | CDC37 | CDC37: Hsp90 co-chaperone Cdc37 | 0.398 | Evidence | |||||
CDC25A | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 0.347 | Evidence | |||||
CDC25A | BMP7 | BMP7, OP1: Bone morphogenetic protein 7 precursor | 0.312 | Evidence | |||||
CDC25A | TPD52L1 | TPD52L1: Tumor protein D53 | 0.31 | Evidence | |||||
CDC25A | PARD6B | PARD6B, PAR6B: Partitioning defective 6 homolog beta | 0.31 | Evidence | |||||
CDC25A | CKS1B | CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 | 0.31 | Evidence | |||||
CDC25A | MCM5 | MCM5, CDC46: DNA replication licensing factor MCM5 | 0.305 | Evidence | |||||
CDC25A | MCM6 | MCM6: DNA replication licensing factor MCM6 | 0.305 | Evidence | |||||
CDC25A | MCM7 | MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 | 0.305 | Evidence | |||||
CDC25A | TFDP1 | TFDP1, DP1: Transcription factor Dp-1 | 0.215 | Evidence | |||||
CDC25A | PRKCD | PRKCD: Protein kinase C, delta | 0.205 | Evidence | |||||
CDC25A | R3HDM2 | R3HDM2, KIAA1002: R3H domain-containing protein 2 | 0.205 | Evidence | |||||
CDC25A | ANKRD20A3 | N/A | 0.205 | Evidence | |||||
CDC25A | EIF2B1 | EIF2B1, EIF2BA: Translation initiation factor eIF-2B subunit alpha | 0.205 | Evidence | |||||
CDC25A | TFDP2 | N/A | 0.193 | Evidence | |||||
CDC25A | REM1 | REM1, GES, REM: GTP-binding protein REM 1 | 0.185 | Evidence | |||||
CDC25A | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 0.185 | Evidence | |||||
CDC25A | SKI | SKI: Ski oncogene | 0.16 | Evidence | |||||
CDC25A | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 0.142 | Evidence | |||||
CDC25A | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 0.142 | Evidence | |||||
CDC25A | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 0.142 | Evidence | |||||
CDC25A | LIMK2 | LIMK2: LIM domain kinase 2 | 0.142 | Evidence | |||||
CDC25A | SRPK2 | SRPK2: Serine/threonine-protein kinase SRPK2 | 0.142 | Evidence | |||||
CDC25A | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 0.142 | Evidence | |||||
CDC25A | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 0.142 | Evidence | |||||
CDC25A | CDKL5 | N/A | 0.142 | Evidence | |||||
CDC25A | MAP2K3 | MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki | 0.142 | Evidence | |||||
CDC25A | NEK3 | NEK3: Serine/threonine-protein kinase Nek3 | 0.142 | Evidence | |||||
CDC25A | YWHAH | YWHAH, YWHA1: 14-3-3 protein eta | 0.142 | Evidence | |||||
CDC25A | PKN1 | PKN1, PKN, PRK1, PRKCL1: Serine/threonine-protein kinase N1 | 0.142 | Evidence | |||||
CDC25A | PIK3CD | PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i | 0.142 | Evidence | |||||
CDC25A | PRKAA1 | N/A | 0.142 | Evidence | |||||
CDC25A | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 0.142 | Evidence | |||||
CDC25A | MAPK15 | N/A | 0.142 | Evidence | |||||
CDC25A | MAPK6 | MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 | 0.142 | Evidence | |||||
CDC25A | TLK1 | TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 | 0.142 | Evidence | |||||
CDC25A | RB1 | RB1: Retinoblastoma-associated protein | 0.142 | Evidence | |||||
CDC25A | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 0.142 | Evidence | |||||
CDC25A | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 0.142 | Evidence | |||||
CDC25A | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 0.142 | Evidence | |||||
CDC25A | MAP2K5 | N/A | 0.142 | Evidence | |||||
CDC25A | PRKR | EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki | 0.142 | Evidence | |||||
CDC25A | YWHAQ | YWHAQ: 14-3-3 protein theta | 0.142 | Evidence | |||||
CDC25A | MAPK10 | MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 | 0.142 | Evidence | |||||
CDC25A | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 0.142 | Evidence | |||||
CDC25A | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 0.142 | Evidence | |||||
CDC25A | DAPK2 | DAPK2: Death-associated protein kinase 2 | 0.142 | Evidence | |||||
CDC25A | MAPK9 | MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 | 0.142 | Evidence | |||||
CDC25A | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 0.142 | Evidence | |||||
CDC25A | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 0.142 | Evidence | |||||
CDC25A | DYRK1A | DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin | 0.142 | Evidence | |||||
CDC25A | BMP2K | BMP2K, BIKE, HRIHFB2017: BMP-2-inducible protein kinase | 0.142 | Evidence | |||||
CDC25A | ICK | ICK, KIAA0936: Serine/threonine-protein kinase ICK | 0.142 | Evidence | |||||
CDC25A | MAPKAPK2 | MAPKAPK2: MAP kinase-activated protein kinase 2 | 0.142 | Evidence | |||||
CDC25A | NEK1 | NEK1, KIAA1901: Serine/threonine-protein kinase Nek1 | 0.142 | Evidence | |||||
CDC25A | MAPK4 | MAPK4, ERK4, PRKM4: Mitogen-activated protein kinase 4 | 0.142 | Evidence | |||||
CDC25A | BMX | N/A | 0.142 | Evidence | |||||
CDC25A | ZAK | MLTK, ZAK, HCCS4: Mitogen-activated protein kinase kinase kinase MLT | 0.142 | Evidence | |||||
CDC25A | CDC2L2 | CDC2L2, CDC2L3, PITSLREB: PITSLRE serine/threonine-protein kinase CDC2L2 | 0.142 | Evidence | |||||
CDC25A | FRAP1 | FRAP1, FRAP, FRAP2: FKBP12-rapamycin complex-associated protein | 0.142 | Evidence | |||||
CDC25A | PASK | PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase | 0.142 | Evidence | |||||
CDC25A | STK16 | N/A | 0.142 | Evidence | |||||
CDC25A | GRK1 | GRK1, RHOK: Rhodopsin kinase precursor | 0.142 | Evidence | |||||
CDC25A | MAPKAPK5 | N/A | 0.142 | Evidence | |||||
CDC25A | CDKN3 | CDKN3, CDI1, CIP2, KAP: Cyclin-dependent kinase inhibitor 3 | 0.135 | Evidence | |||||
CDC25A | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 0.128 | Evidence | |||||
CDC25A | PRKAA2 | PRKAA2, AMPK, AMPK2: 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0.128 | Evidence | |||||
CDC25A | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 0.128 | Evidence | |||||
CDC25A | CRKRS | CRKRS, CRK7, KIAA0904: Cell division cycle 2-related protein kinase 7 | 0.128 | Evidence | |||||
CDC25A | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 0.128 | Evidence | |||||
CDC25A | SCYL3 | SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin | 0.128 | Evidence | |||||
CDC25A | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 0.128 | Evidence | |||||
CDC25A | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 0.128 | Evidence | |||||
CDC25A | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 0.128 | Evidence | |||||
CDC25A | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 0.128 | Evidence | |||||
CDC25A | CDK5R1 | CDK5R1, CDK5R, NCK5A: Cyclin-dependent kinase 5 activator 1 precursor | 0.128 | Evidence | |||||
CDC25A | MAPKAPK3 | MAPKAPK3: MAP kinase-activated protein kinase 3 | 0.128 | Evidence | |||||
CDC25A | NEK7 | NEK7: Serine/threonine-protein kinase Nek7 | 0.128 | Evidence | |||||
CDC25A | PAK6 | PAK6, PAK5: Serine/threonine-protein kinase PAK 6 | 0.128 | Evidence | |||||
CDC25A | CCNL1 | CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 | 0.128 | Evidence | |||||
CDC25A | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 0.128 | Evidence | |||||
CDC25A | CCND1 | CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 | 0.128 | Evidence | |||||
CDC25A | ILK | ILK, ILK1, ILK2: Integrin-linked protein kinase | 0.128 | Evidence | |||||
CDC25A | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 0.128 | Evidence | |||||
CDC25A | NRBP1 | NRBP1, BCON3, NRBP: Nuclear receptor-binding protein | 0.128 | Evidence | |||||
CDC25A | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 0.128 | Evidence | |||||
CDC25A | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 0.128 | Evidence | |||||
CDC25A | SYK | SYK: Tyrosine-protein kinase SYK | 0.128 | Evidence | |||||
CDC25A | CDC2L5 | CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 | 0.128 | Evidence | |||||
CDC25A | KIAA1804 | MLK4, KIAA1804: Mitogen-activated protein kinase kinase kinase | 0.128 | Evidence | |||||
CDC25A | VRK1 | VRK1: Serine/threonine-protein kinase VRK1 | 0.128 | Evidence | |||||
CDC25A | PAK7 | PAK7, KIAA1264, PAK5: Serine/threonine-protein kinase PAK 7 | 0.128 | Evidence | |||||
CDC25A | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 0.128 | Evidence | |||||
CDC25A | PCTK1 | PCTK1: Serine/threonine-protein kinase PCTAIRE-1 | 0.128 | Evidence | |||||
CDC25A | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 0.128 | Evidence | |||||
CDC25A | CHEK2 | CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 | 0.128 | Evidence | |||||
CDC25A | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 0.128 | Evidence | |||||
CDC25A | MAPK12 | MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 | 0.128 | Evidence | |||||
CDC25A | CCT2 | CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta | 0.128 | Evidence | |||||
CDC25A | CAMK2D | CAMK2D, CAMKD: Calcium/calmodulin-dependent protein kinase type II delta chain | 0.128 | Evidence | |||||
CDC25A | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 0.128 | Evidence | |||||
CDC25A | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 0.128 | Evidence | |||||
CDC25A | CDC2 | CDC2: Cell division control protein 2 homolog | 0.128 | Evidence | |||||
CDC25A | CHEK1 | CHEK1, CHK1: Serine/threonine-protein kinase Chk1 | 0.128 | Evidence | |||||
CDC25A | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 0.128 | Evidence | |||||
CDC25A | YWHAE | YWHAE: 14-3-3 protein epsilon | 0.128 | Evidence | |||||
CDC25A | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 0.128 | Evidence | |||||
CDC25A | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 0.128 | Evidence | |||||
CDC25A | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 0.128 | Evidence | |||||
CDC25A | HIPK2 | HIPK2: Homeodomain-interacting protein kinase 2 | 0.128 | Evidence | |||||
CDC25A | STK24 | STK24, MST3, STK3: Serine/threonine-protein kinase 24 | 0.128 | Evidence | |||||
CDC25A | LYN | LYN: Tyrosine-protein kinase Lyn | 0.128 | Evidence | |||||
CDC25A | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 0.128 | Evidence | |||||
CDC25A | EEF2K | EEF2K: Elongation factor 2 kinase | 0.128 | Evidence | |||||
CDC25A | CAMK1 | CAMK1: Calcium/calmodulin-dependent protein kinase type 1 | 0.128 | Evidence | |||||
CDC25A | PKN3 | PKN3, PKNBETA: Serine/threonine-protein kinase N3 | 0.128 | Evidence | |||||
CDC25A | MAP3K7 | MAP3K7, TAK1: Mitogen-activated protein kinase kinase kinase 7 | 0.128 | Evidence | |||||
CDC25A | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 0.128 | Evidence | |||||
CDC25A | GTF2B | GTF2B, TF2B, TFIIB: Transcription initiation factor IIB | 0.128 | Evidence | |||||
CDC25A | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 0.128 | Evidence | |||||
CDC25A | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 0.128 | Evidence | |||||
CDC25A | C10orf9 | CCNY, C10orf9, CBCP1, CFP1: Cyclin-Y | 0.128 | Evidence | |||||
CDC25A | HIPK3 | HIPK3, DYRK6, FIST3, PKY: Homeodomain-interacting protein kinase 3 | 0.128 | Evidence | |||||
CDC25A | JAK1 | 0.128 | Evidence | ||||||
CDC25A | PIK3C2A | PIK3C2A: Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing alpha po | 0.128 | Evidence | |||||
CDC25A | PRKG1 | PRKG1, PRKG1B, PRKGR1B: cGMP-dependent protein kinase 1, beta isozyme | 0.128 | Evidence | |||||
CDC25A | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 0.128 | Evidence | |||||
CDC25A | MAP3K10 | MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 | 0.128 | Evidence | |||||
CDC25A | STK3 | STK3, MST2: Serine/threonine-protein kinase 3 | 0.128 | Evidence | |||||
CDC25A | NEK8 | NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 | 0.128 | Evidence | |||||
CDC25A | RPS6KB2 | RPS6KB2, STK14B: Ribosomal protein S6 kinase beta-2 | 0.128 | Evidence | |||||
CDC25A | CCNT2 | CCNT2: Cyclin-T2 | 0.128 | Evidence | |||||
CDC25A | PSKH1 | PSKH1: Serine/threonine-protein kinase H1 | 0.128 | Evidence | |||||
CDC25A | CDK6 | CDK6: Cell division protein kinase 6 | 0.128 | Evidence | |||||
CDC25A | AURKA | AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 | 0.128 | Evidence | |||||
CDC25A | OXSR1 | OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 | 0.128 | Evidence | |||||
CDC25A | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 0.128 | Evidence | |||||
CDC25A | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 0.128 | Evidence | |||||
CDC25A | YWHAZ | YWHAZ: 14-3-3 protein zeta/delta | 0.128 | Evidence | |||||
CDC25A | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 0.128 | Evidence | |||||
CDC25A | CAMK4 | CAMK4: Calcium/calmodulin-dependent protein kinase type IV | 0.128 | Evidence | |||||
CDC25A | MYO3A | MYO3A: Myosin IIIA | 0.128 | Evidence | |||||
CDC25A | MKNK2 | MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 | 0.128 | Evidence | |||||
CDC25A | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 0.128 | Evidence | |||||
CDC25A | RPS6KB1 | N/A | 0.128 | Evidence | |||||
CDC25A | MAP2K4 | MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k | 0.128 | Evidence | |||||
CDC25A | ATM | ATM: Serine-protein kinase ATM | 0.128 | Evidence | |||||
CDC25A | STK11 | STK11, LKB1, PJS: Serine/threonine-protein kinase 11 | 0.128 | Evidence | |||||
CDC25A | CAMK1D | CAMK1D: Calcium/calmodulin-dependent protein kinase type 1D | 0.128 | Evidence | |||||
CDC25A | SGK3 | SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 | 0.128 | Evidence | |||||
CDC25A | PRKD2 | PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 | 0.128 | Evidence | |||||
CDC25A | STK39 | STK39, SPAK: STE20/SPS1-related proline-alanine-rich protein kinase | 0.128 | Evidence | |||||
CDC25A | DYRK3 | N/A | 0.128 | Evidence | |||||
CDC25A | SGK | SGK, SGK1: Serine/threonine-protein kinase Sgk1 | 0.128 | Evidence | |||||
CDC25A | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 0.128 | Evidence | |||||
CDC25A | MOS | MOS: Proto-oncogene serine/threonine-protein kinase mos | 0.128 | Evidence | |||||
CDC25A | CDK4 | CDK4: Cell division protein kinase 4 | 0.128 | Evidence | |||||
CDC25A | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 0.128 | Evidence | |||||
CDC25A | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 0.128 | Evidence | |||||
CDC25A | CDK5 | CDK5: Cell division protein kinase 5 | 0.128 | Evidence | |||||
CDC25A | STK4 | STK4, MST1: Serine/threonine-protein kinase 4 | 0.128 | Evidence | |||||
CDC25A | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 0.128 | Evidence | |||||
CDC25A | PHKG1 | PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo | 0.128 | Evidence | |||||
CDC25A | MAPK13 | MAPK13, PRKM13, SAPK4: Mitogen-activated protein kinase 13 | 0.128 | Evidence | |||||
CDC25A | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 0.128 | Evidence | |||||
CDC25A | HCK | N/A | 0.128 | Evidence | |||||
CDC25A | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 0.128 | Evidence | |||||
CDC25A | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 0.128 | Evidence | |||||
CDC25A | GRK5 | GRK5, GPRK5: G protein-coupled receptor kinase 5 | 0.128 | Evidence | |||||
CDC25A | LIMK1 | LIMK1, LIMK: LIM domain kinase 1 | 0.128 | Evidence | |||||
CDC25A | SOS1 | SOS1: Son of sevenless homolog 1 | 0.128 | Evidence | |||||
CDC25A | MAP3K11 | MAP3K11, MLK3, PTK1, SPRK: Mitogen-activated protein kinase kinase kinase 11 | 0.128 | Evidence | |||||
CDC25A | NEK9 | NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 | 0.128 | Evidence | |||||
CDC25A | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 0.128 | Evidence | |||||
CDC25A | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 0.128 | Evidence | |||||
CDC25A | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 0.128 | Evidence | |||||
CDC25A | WNK4 | WNK4, PRKWNK4: Serine/threonine-protein kinase WNK4 | 0.128 | Evidence | |||||
CDC25A | SNF1LK2 | SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 | 0.128 | Evidence | |||||
CDC25A | TBK1 | TBK1, NAK: Serine/threonine-protein kinase TBK1 | 0.128 | Evidence | |||||
CDC25A | DYRK1B | DYRK1B, MIRK: Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0.128 | Evidence | |||||
CDC25A | STK10 | STK10: Uncharacterized protein STK10 | 0.128 | Evidence | |||||
CDC25A | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 0.128 | Evidence | |||||
CDC25A | ROCK2 | ROCK2, KIAA0619: Rho-associated protein kinase 2 | 0.128 | Evidence |